BIOTRONIK has announced the opening of its new Asia Pacific Manufacturing and Research Hub. The 20,000 m² site will serve as the company’s central hub in Asia Pacific, with hundreds of employees working in manufacturing, quality, research & development (R&D), and sales and marketing.

BIOTRONIK, founded in Berlin, Germany, in 1963 is a pioneer in implantable pacemakers, defibrillators, and vascular intervention for 60 years. BIOTRONIK’s presence in Singapore began in 2012, and in 2016, the company inaugurated its first manufacturing site, complementing its high-quality manufacturing sites in Germany, Switzerland and the United States.

Now in 2023, the new facility has been designed with an emphasis on workspace agility for modern, optimized collaboration. The new site includes several spacious cleanrooms and laboratories developing and manufacturing state-of-the art Cardiac Rhythm Management (CRM) devices.

“We are excited to be the first major manufacturer in the cardiac rhythm management sector to set up an Asia Pacific manufacturing and research hub which incorporates both product R&D and manufacturing,” said Peter Horan, Managing Director, Asia Pacific Manufacturing, BIOTRONIK.

“Singapore is well placed to serve the growing regional demand for healthcare innovation and solutions with our thriving ecosystem, robust IP protection, and strong talent pool. BIOTRONIK’s latest expansion demonstrates how multinational companies can plug into our local MedTech and R&D capabilities to develop and manufacture quality products for global markets,“ said Jacqueline Poh, Managing Director, Singapore Economic Development Board.